Apply the most advanced technology in the world to production of influenza vaccine and arrange vaccine production and quality control according to current influenza virus recommended by WHO. Each quality index of the influenza vaccine is excellent.
(1) Obtain National Ten Famous-brand Products Honor Certificate in pharmaceutical industry；
(2) Apply centrifugal purification and column chromatography purification technology to purifying virus and the patent certificate of making use of Sepharose4FF column chromatography technology for vaccine manufacture, gaining excellent quality index and high purity；
(3) High-level GMT of conversion rate of serum antibody with safety and reliable effect for prevention；
(4) Various Specifications：
a. Vial type for adult: 0.5ml/vial for people above 3 years old；
Vial type for children：0.25ml/vial for children from 6 to 35 months old；
b. Syringe type for adult: 0.5ml/syringe for people above 3 years old；
Syringe type for children：0.25ml/syringe for children from 6 to 35 months old；
(5) Exclusively apply two dosage forms of pre-filled syringe from American BD Company and vial pack for security and convenience;
(6) Award Influenza Split Vaccine as the Hi-tech Industrial Model Project in the First Batch Hi-tech Industrial Program in the Special Hi-tech Industrial Development of Rebuilding the Old Industrial Base in Northeast by State Development and Reform Committee；
(7) Rated as National New and Key Product by the Ministry of Science and Technology, Ministry of Foreign Trade and Economic Cooperation, State General Administration of Supervision, Inspection and Quarantine, State Environmental Protection Administration of China; rated as Excellent Technology Product by China Association for Science and Technology; award the Honor of Science and Technology Progress by Changchun City Administration of Science and Technology；
(8) Successfully registered in over 20 countries and export to dozens of countries for consecutive years.